Background A wide range of drugs have been studied for first trimester medical abortion.
Studies evaluating different regimens, including combination mifepristone and misoprostol …

Background. The aim of this study was to determine the effectiveness of medical abortions
with mifepristone and misoprostol following the approval of medical abortion in Israel …

Objective Abortion-related complications remain one of the leading causes of maternal
morbidity and mortality worldwide. Nearly half of all abortions are unsafe, and the vast …

Multiple clinical studies demonstrate the efficacy of medical abortion with mifepristone or
methotrexate followed by a prostaglandin analogue. However, assessing predictors of …

This study assessed the efficacy and side effects of first trimester medical abortion using
mifepristone and vaginally administered misoprostol. Medical abortion was first introduced …

Objectives To compare the efficacy of two different regimens of mifepristone followed by
misoprostol for medical abortion in women with menstrual delay of≤ 35 days. Design …

Objective To evaluate outcomes with mifepristone 200 mg orally followed 24–48 h later by
misoprostol 800 mcg vaginally for medical abortion at 64–70 days of gestation. Study design …

Pregnancy can be terminated safely by inducing abortion medically at any stage of
gestation. Antagonists such as mifepristone block the action of progesterone and hence …

This commentary introduces the Medical Abortion Reporting of Efficacy (MARE) guidelines
as a supplement to CONSORT [1] and STROBE [2]. The goal of the recommendations is to …

Background Medical abortion became an alternative method of pregnancy termination
following the development of prostaglandins and antiprogesterone in the 1970s and 1980s …